Micro-needles are new form of dose delivery systems, which can easily overcome various problems associated with the conventional formulations. Microneedle device consists of needles of micron size, which are arranged on a small dermal patch. The main principle of micro-needles include disruption of the skin layer, thus creating micron size pathway for drug delivery, in which the drugs can easily be transferred from epidermis or upper dermis region directly to the systemic circulation without facing any barrier. Micro-needles are of various types such as dissolving micro-needles, coated micro-needles, hollow micro-needles, and fabricated like solid micro-needles.
This report contains market size and forecasts of Microneedle Flu Vaccine in global, including the following market information:
Global Microneedle Flu Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Microneedle Flu Vaccine Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Microneedle Flu Vaccine companies in 2021 (%)
The global Microneedle Flu Vaccine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Solid Microneedle Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Microneedle Flu Vaccine include Sanofi, GC Pharma, Debiotech, NanoPass Technologies, Corium International, Becton Dickinson and Company, FluGen, CosMED Pharmaceuticals and Microdermics and OraSure Technologies. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Microneedle Flu Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Microneedle Flu Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Microneedle Flu Vaccine Market Segment Percentages, by Type, 2021 (%)
Solid Microneedle
Hollow Microneedle
Coated Microneedle
Dissolving Microneedle
Global Microneedle Flu Vaccine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Microneedle Flu Vaccine Market Segment Percentages, by Application, 2021 (%)
Influenza A
Influenza B
Global Microneedle Flu Vaccine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Microneedle Flu Vaccine Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Microneedle Flu Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Microneedle Flu Vaccine revenues share in global market, 2021 (%)
Key companies Microneedle Flu Vaccine sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Microneedle Flu Vaccine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
GC Pharma
Debiotech
NanoPass Technologies
Corium International
Becton Dickinson and Company
FluGen
CosMED Pharmaceuticals
Microdermics and OraSure Technologies